4.7 Article

Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia - A report from the childhood cancer survivor study

Journal

CANCER
Volume 112, Issue 9, Pages 2071-2079

Publisher

WILEY
DOI: 10.1002/cncr.23405

Keywords

acute myeloid leukemia; survivorship; medical late effects; social late effects

Categories

Funding

  1. NCI NIH HHS [U24 CA055727, U24 CA 55727] Funding Source: Medline
  2. NCRR NIH HHS [K12 RR023247, 1 K12 RR 023247] Funding Source: Medline

Ask authors/readers for more resources

BACKGROUND. Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML). METHODS. This analysis included 272 5-year AML survivors who participated in the Childhood Cancer Survivor Study (CCSS). All patients were diagnosed at age <= 21 years between the years 1970 and 1986, and none underwent stem cell transplantation. Rates of survival, relapse, and late outcomes were analyzed. RESULTS. The average follow-up was 20.5 years (range, 5-33 years). The overall survival rate was 97% at 10 years (95% confidence interval [95%CI], 94%-98%) and 94% at 20 years (95% CL 90%-96%). Six survivors reported 8 recurrences. The cumulative incidence of recurrent AML was 6.6% at 10 years (95% CI, 3.7%-9.6%) and 8.6% at 20 years (95% CI, 5.1%-12.1%). Ten subsequent malignant neoplasms (SMN) were reported, including 4 with a history of radiation therapy, for a 20-year cumulative incidence of 1.7% (95% CI, 0.02%-3.4%). Six cardiac events were reported, for a 20-year cumulative incidence 4.7% (95% CI, 2.1%-7.3%). Half of the survivors reported a chronic medical condition and, compared with siblings, were at increased risk for severe or life-threatening chronic medical conditions (16% vs 5.8%; P <.001). Among those aged >= 25 years, the age-adjusted marriage rates were similar among survivors and the general United States population (57% for both) and lower compared with siblings (67%; P <.01). Survivors' college graduation rates were lower compared with siblings but higher than the general population (40% vs 52% vs 34%, respectively; P <.01). Employment rates were similar between survivors, siblings, and the general population (93%, 97.6%, and 95.8%, respectively). CONCLUSIONS. Long-term survival from childhood AML >= 5-years after diagnosis was favorable. Late-occurring medical events remained a concern with socioeconomic achievement lower than expected within the individual family unit, although it was not different from the general United States population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Immunology

Laparoscopic Sleeve Gastrectomy for Obesity After Combined Liver-intestinal Transplantation: A Case Report

Mathias Clarysse, Pieter Van Aelst, Tim Vanuytsel, Diethard Monbaliu, Laurens J. Ceulemans, Ann Mertens, Roman Vangoitsenhoven, Bart van der Schueren, Matthias Lannoo, Jacques Pirenne, Ellen Deleus

TRANSPLANTATION (2023)

Article Oncology

The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada

Hallie Coltin, Priscila Pequeno, Ning Liu, Derek S. Tsang, Sumit Gupta, Michael D. Taylor, Eric Bouffet, Paul C. Nathan, Vijay Ramaswamy

Summary: This study characterized the late effects of childhood medulloblastoma survivors using real-world health services data. The findings reveal significant long-term medical sequelae and increased mortality rates, emphasizing the need for a re-evaluation of current treatment approaches and prioritization of interventions targeting late effects.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer

AnnaLynn M. Williams, Jeanne Mandelblatt, Mingjuan Wang, Gregory T. Armstrong, Nickhill Bhakta, Tara M. Brinkman, Wassim Chemaitilly, Matthew J. Ehrhardt, Daniel A. Mulrooney, Brent J. Small, Zhaoming Wang, Deokumar Srivastava, Leslie L. Robison, Melissa M. Hudson, Kirsten K. Ness, Kevin R. Krull

Summary: This study aimed to compare the accumulation of deficits in survivors of pediatric cancer with community controls and examine associations with host and treatment factors, neurocognition, and mortality. The results showed that pediatric cancer survivors experience clinically significant premature aging, with a DAI score of 0.16 at age 30 corresponding to age 63 in controls (33 years premature aging). Higher DAI scores were associated with increased risk of neurocognitive impairment and death.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Dentistry, Oral Surgery & Medicine

Factors for poor oral health in long-term childhood cancer survivors

Tushar Patni, Chun-Teh Lee, Yimei Li, Sue Kaste, Liang Zhu, Ryan Sun, Melissa M. Hudson, Kirsten K. Ness, Ana Neumann, Leslie L. Robison

Summary: This study investigated the associations between clinical, socioeconomic, and demographic factors and oral diseases in childhood cancer survivors. The results showed that survivors had a higher prevalence of microdontia, abnormal root development, hypodontia, enamel hypoplasia, xerostomia, severe gingivitis, and missing teeth compared to controls. Cancer treatment, socioeconomic factors, and access to oral health care contributed to the prevalence of dental abnormalities.

BMC ORAL HEALTH (2023)

Review Oncology

Ten Considerations for Integrating Patient-Reported Outcomes into Clinical Care for Childhood Cancer Survivors

Madeline R. Horan, Jin-ah Sim, Kevin R. Krull, Kirsten K. Ness, Yutaka Yasui, Leslie L. Robison, Melissa M. Hudson, Justin N. Baker, I-Chan Huang

Summary: Patient-reported outcome measures (PROMs) are useful in assessing the subjective experiences of childhood cancer survivors and can be used to monitor health status and inform medical decision making. This article provides 10 important considerations for clinicians when assessing PROMs for childhood cancer survivors, addressing practical barriers and solutions. An example framework for integrating PROMs into clinical workflow using cutting-edge technologies is also discussed.

CANCERS (2023)

Editorial Material Oncology

Making sense of the risks: what to tell adolescents and young adults diagnosed with cancer during pregnancy

Paul C. Nathan, H. Irene Su

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer

Kohei Hagiwara, Sivaraman Natarajan, Zhaoming Wang, Haseeb Zubair, Heather L. Mulder, Li Dong, Emily M. Plyler, Padma Thimmaiah, Xiaotu Ma, Kristen K. Ness, Zhenghong Li, Daniel A. Mulrooney, Carmen L. Wilson, Yutaka Yasui, Melissa M. Hudson, John Easton, Leslie L. Robison, Jinghui Zhang

Summary: This study provides the first comprehensive investigation of clonal hematopoiesis (CH) in long-term survivors of pediatric cancer. The results show a higher prevalence of CH mutations in survivors compared to community controls. The study also identifies specific genes associated with therapy-related CH in survivors of Hodgkin lymphoma.

CANCER DISCOVERY (2023)

Article Oncology

Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort

Qian Dong, Cheng Chen, Nan Song, Na Qin, Noel-Marie Plonski, Emily R. Finch, Kyla Shelton, John Easton, Heather Mulder, Emily Plyer, Geoffrey Neale, Emily Walker, Qian Li, I-Chan Huang, Jinghui Zhang, Hui Wang, Melissa M. Hudson, Leslie L. Robison, Kirsten K. Ness, Zhaoming Wang

Summary: This study conducted an epigenome-wide association analysis on childhood cancer survivors using blood lipid data from the St. Jude lifetime cohort study. The findings revealed that DNA methylation levels of different genes were associated with blood lipid levels, and there were differences between populations of different genetic ancestries. These findings provide insights into the molecular mechanisms of lipid metabolism in childhood cancer survivors.

CLINICAL EPIGENETICS (2023)

Article Oncology

Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population-based cohort study

Vicky R. Breakey, Rinku Sutradhar, Paul C. Nathan, Serina Patel, Laura Wheaton, Qing Li, Mylene Bassal, Paul Gibson, Jason D. Pole, Uma Athale, Sumit Gupta

Summary: Patient re-engagement with primary care physicians (PCPs) during and after treatment for acute lymphoblastic leukemia (ALL) is low. Involvement of PCPs during treatment can improve post-treatment engagement with PCPs among ALL survivors.

PEDIATRIC BLOOD & CANCER (2023)

Article Oncology

A qualitative exploration of parental caregivers' experience caring for children who have survived medulloblastoma

Priya Sayal, Sara Rizakos, Emily Lam, Julie Constantin, Catherine Diskin, Ute Bartels, Julia Orkin, Paul C. Nathan

Summary: This study aimed to explore the experience of parental caregivers caring for medulloblastoma survivors. The study found that parental caregivers face long-term challenges and personal and family impacts. The conclusion of this study is that further improvement is needed in care models and support systems for families with a child who has survived medulloblastoma.

PEDIATRIC BLOOD & CANCER (2023)

Review Environmental Sciences

A perspective on green, blue, and grey spaces, biodiversity, microbiota, and human health

John D. Potter, Collin Brooks, Geoffrey Donovan, Chris Cunningham, Jeroen Douwes

Summary: Humans' encroachment into wild spaces has profound impacts on our relationship with nature, the survival of other species, pollution, and climate change. The benefits of being close to green and blue spaces are discussed, while the hazards of urban grey spaces are highlighted. The biodiversity hypothesis and the role of microbiota are emphasized, along with possible mechanisms of exposure through air, soil, and water. The importance of assessing exposure accurately and the need for implementing policies to restore environmental balance are also emphasized.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Oncology

Phase II study of everolimus for recurrent or progressive pediatric ependymoma

Daniel C. Bowers, Veena Rajaram, Matthias A. Karajannis, Sharon L. Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J. Klesse

Summary: This phase II clinical trial evaluated the efficacy of everolimus, an mTOR pathway inhibitor, for children with recurrent or progressive posterior fossa-A (PF-A) ependymomas. The study showed that everolimus did not lead to objective tumor responses in these patients. Adverse events were generally mild, with only one case of grade 3 pneumonia.

NEURO-ONCOLOGY ADVANCES (2023)

Meeting Abstract Oncology

Sugar Intake and premature aging in adult survivors of childhood cancer in the St. Jude Lifetime (SJLIFE) Cohort

Tuo Lan, Mei Wang, AnnaLynn M. Williams, Matthew J. Ehrhardt, Emily R. Finch, Jennifer Q. Lanctot, Shu Jiang, Kevin R. Krull, Gregory T. Armstrong, Melissa M. Hudson, Graham A. Colditz, Leslie Robison, Kirsten K. Ness, Yikyung Park

CANCER RESEARCH (2023)

Article Oncology

Late effects in survivors of post-transplant lymphoproliferative disease

Mary Claire Mcglynn, Kassidy Brady, Jessica M. Healey, Vikas R. Dharnidharka, A. Marion Ybarra, Janis Stoll, Stuart Sweet, Robert J. Hayashi

Summary: Survivors of PTLD experience late effects (LE), including late mortality, regardless of chemotherapy exposure. Chemotherapy does not affect survival rate, but is associated with higher incidence of blood and lymphatic toxicity as well as cardiac toxicity, and lower incidence of infections.

PEDIATRIC BLOOD & CANCER (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

A RETROSPECTIVE STUDY OF SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN A BELGIAN LIPID CLINIC

V. Ide, D. De Cock, R. Vangoitsenhoven, B. Van Der Schueren, A. Mertens

ATHEROSCLEROSIS (2023)

No Data Available